MedMen Enterprises Inc.
MMNFQ
$0.00
$0.000.00%
OTC PK
| 03/25/2023 | 12/24/2022 | 09/24/2022 | 06/25/2022 | 03/26/2022 | |
|---|---|---|---|---|---|
| Revenue | -22.77% | -16.79% | -18.22% | -12.38% | 10.62% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -22.77% | -16.79% | -18.22% | -12.38% | 10.62% |
| Cost of Revenue | -21.97% | -17.78% | -21.51% | -19.62% | -7.77% |
| Gross Profit | -23.60% | -15.81% | -14.55% | -4.37% | 39.85% |
| SG&A Expenses | -35.18% | -41.51% | -44.98% | -29.86% | 11.10% |
| Depreciation & Amortization | -42.08% | -45.50% | -32.23% | 24.30% | -19.81% |
| Other Operating Expenses | 160.08% | -814.02% | -8,960.71% | -408.97% | -1,958.76% |
| Total Operating Expenses | -21.62% | -37.47% | -38.52% | -25.10% | -7.00% |
| Operating Income | 18.12% | 72.43% | 72.96% | 49.70% | 37.40% |
| Income Before Tax | -87.87% | 14.24% | 31.76% | -258.17% | 57.34% |
| Income Tax Expenses | -357,926.67% | 113.04% | -88.86% | -7,566.62% | 100.00% |
| Earnings from Continuing Operations | -60.29% | -83.59% | 56.12% | -189.54% | -50.89% |
| Earnings from Discontinued Operations | 63.31% | 81.42% | 268.25% | 16.82% | -433.28% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1,122.96% | -14.75% | -97.87% | 19.79% | 107.38% |
| Net Income | -5.85% | 14.82% | 107.52% | -134.68% | -116.85% |
| EBIT | 18.12% | 72.43% | 72.96% | 49.70% | 37.40% |
| EBITDA | -1.96% | 110.75% | 87.76% | 80.57% | 36.02% |
| EPS Basic | 4.86% | 22.01% | 105.45% | -25.13% | 12.10% |
| Normalized Basic EPS | -37.04% | 27.03% | 48.82% | 99.49% | 88.58% |
| EPS Diluted | 18.40% | 38.31% | 105.45% | -25.13% | -2.49% |
| Normalized Diluted EPS | -37.04% | 27.03% | 48.82% | 99.49% | 88.58% |
| Average Basic Shares Outstanding | 11.52% | 8.62% | 38.08% | 87.59% | 122.25% |
| Average Diluted Shares Outstanding | 11.52% | 8.62% | 38.08% | 87.59% | 122.25% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |